Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTEGRA LIFESCIENCES HOLDINGS CORPORATION

(IART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Integra LifeSciences : Announces Participation in Upcoming Investor Conferences

09/02/2021 | 04:01pm EDT

PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

  • On September 9, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Wells Fargo 2021 Virtual Healthcare Conference at 11:20am ET.
  • On September 13, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley 19th Annual Global Healthcare Conference at 1:15pm ET.

Webcast information can be found on the Company’s website at Investor Relations.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, MatriStem® UBM, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Michael Beaulieu
(609) 529-4812
michael.beaulieu@integralife.com  

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com


Primary Logo

Source: Integra LifeSciences Holdings Corporation

2021 GlobeNewswire, Inc., source Press Releases

All news about INTEGRA LIFESCIENCES HOLDINGS CORPORATION
10/06INTEGRA LIFESCIENCES : to Host Third Quarter 2021 Financial Results Conference Call on Nov..
AQ
09/15INTEGRA LIFESCIENCES : BTIG Downgrades Integra LifeSciences Holdings to Neutral from Buy
MT
09/07INSIDER SELL : Integra Lifesciences Holdings
MT
09/02INTEGRA LIFESCIENCES : Announces Participation in Upcoming Investor Conferences
AQ
08/10INSIDER TRENDS : 90-Day Insider Buying Trend at Integra LifeSciences Holdings Slowed with ..
MT
07/29INTEGRA LIFESCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
07/29Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan annou..
CI
07/28INTEGRA LIFESCIENCES : Q2 Adjusted Earnings, Revenue Rise; Issues Q3 Guidance, Updates Ful..
MT
07/28INTEGRA LIFESCIENCES : Reports Second Quarter 2021 Financial Results Raises Full-Year 2021..
PU
07/28INTEGRA LIFESCIENCES HOLDINGS CORP : Results of Operations and Financial Condition, Financ..
AQ
More news
Analyst Recommendations on INTEGRA LIFESCIENCES HOLDINGS CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 544 M - -
Net income 2021 157 M - -
Net Debt 2021 954 M - -
P/E ratio 2021 38,5x
Yield 2021 -
Capitalization 5 990 M 5 990 M -
EV / Sales 2021 4,50x
EV / Sales 2022 4,03x
Nbr of Employees 3 700
Free-Float 81,2%
Chart INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Duration : Period :
Integra LifeSciences Holdings Corporation Technical Analysis Chart | IART | US4579852082 | MarketScreener
Technical analysis trends INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 70,82 $
Average target price 77,45 $
Spread / Average Target 9,37%
EPS Revisions
Managers and Directors
Peter J. Arduini President, Chief Executive Officer & Director
Carrie Anderson Chief Financial Officer, Treasurer & Executive VP
Stuart M. Essig Chairman
Kenneth E. Burhop Chief Scientific Officer & Vice President
William Compton Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
INTEGRA LIFESCIENCES HOLDINGS CORPORATION9.09%5 990
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815